The investigation of hepatoprotective and antioxidant properties of Osmanthus fragrans on experimental model of chronic alcoholic liver damage in vivo

Authors

  • Aksana I. Hubich Belarusian State University, 4 Niezaliezhnasci Avenue, Minsk 220030, Belarus
  • Anton P. Shpak Belarusian State University, 4 Niezaliezhnasci Avenue, Minsk 220030, Belarus

Keywords:

chronic alcohol intoxication, hepatoprotection, lipid peroxidation, Osmanthus fragrans, antioxidant effect

Abstract

The possibility of Osmanthus fragrans decoctions to stabilise the values of biochemical markers of liver damage and lipid peroxidation in rats on an experimental model of chronic alcohol intoxication was analysed. It was found that Osmanthus fragrans decoction has the antioxidant and hepatoprotective effects on rats with experimental alcoholic liver damage, exceeding the effect of the comparison drug – the pharmacy hepatoprotective herbal collection «Phytolekar dlya pecheni» («Phytolekar for liver»). The introduction of the analysed decoction into the diet of animals with alcoholic liver damage for 20 days contributed to a decrease in TBA-active products content in their liver homogenate by 75.5 % and an increase in SH-groups level by 129.3 % compared to similar indicators of rats suffering from this experimental pathology but not receiving the drug and was accompanied by a tendency to an increase of catalase activity. A decrease in peroxidation processes intensity in the liver, in turn, ensured normalisation of the biochemical markers of liver damage such as concentration of total bilirubin and albumin, activity of alanine aminotransferase and alkaline phosphatase in the experimental animals serum. These effects may be due to the high content of bioflavonoids, phenolic acids, vitamins of group E, unsaturated fatty acids and ionones in the composition of Osmanthus fragrans, which exhibit antioxidant properties.

Author Biographies

  • Aksana I. Hubich, Belarusian State University, 4 Niezaliezhnasci Avenue, Minsk 220030, Belarus

    PhD (biology), docent; associate professor at the department of biochemistry, faculty of biology

  • Anton P. Shpak, Belarusian State University, 4 Niezaliezhnasci Avenue, Minsk 220030, Belarus

    student at the faculty of biology

References

  1. Xie Y-D, Feng B, Gao Y. Effect of abstinence from alcohol on survival of patients with alcoholic cirrhosis: a systematic review and meta-analysis. Hepatology Research. 2014;44(4):436–449. DOI: 10.1111/hepr.12131.
  2. Скворцов ВВ, Луньков МВ, Левитан БН. Комбинированная фитотерапия при хронической алкогольной болезни печени. Медицинский совет. 2020;15:97–103. DOI: 10.21518/2079-701X-2020-15-97-103.
  3. Ивашкин ВТ, Маевская МВ, Павлов ЧС, Сиволап ЮП, Луньков ВД, Жаркова МС и др. Клинические рекомендации Российского общества по изучению печени по ведению взрослых пациентов с алкогольной болезнью печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017;27(6):20–40. EDN: YQEEDK.
  4. Маевская МВ, Морозова МА, Ивашкин ВТ. Алгоритм ведения пациентов с алкогольной болезнью печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2011;21(1):4–10. EDN: NUQDEX.
  5. Wang B, Luan F, Bao Y, Peng X, Rao Z, Tang Q, et al. Traditional uses, phytochemical constituents and pharmacological properties of Osmanthus fragrans: a review. Journal of Ethnopharmacology. 2022;293:115273. DOI: 10.1016/j.jep.2022.115273.
  6. Yan X, Zhang T. Review of Osmanthus fragrans planting and utilizations in China. Journal of Agriculture and Social Research. 2006;6(2):40–46. DOI: 10.4314/jasr.v6i2.47015.
  7. Fu C-C, Xu F-Y, Qian Y-C, Koo H-L, Duan Y-F, Weng G-M, et al. Secondary metabolites of Osmanthus fragrans: metabolism and medicinal value. Frontiers in Pharmacology. 2022;13:922204. DOI: 10.3389/fphar.2022.922204.
  8. Aebi H. Catalase in vitro. In: Packer L, editor. Oxygen radicals in biological systems. Orlando: Academic Press; 1984. p. 121–126 (Colowick SP, Kaplan NO, editors. Methods in enzymology; volume 105). DOI: 10.1016/S0076-6879(84)05016-3.
  9. Ellman GL. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics. 1959;82(1):70–77. DOI: 10.1016/0003-9861(59)90090-6.
  10. Хомерики СГ, Хомерики НМ. Алкогольная болезнь печени: механизмы развития, морфологические проявления, дифференциальная диагностика и патогенетические подходы к терапии. Гастроэнтерология. Приложение к журналу «Consilium Medicum». 2012;1:27–34. EDN: RXDZLZ.
  11. Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nature Reviews Disease Primers. 2018;4:16. DOI: 10.1038/s41572-018-0014-7.
  12. Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nature Reviews Gastroenterology & Hepatology. 2015;12(4):231–242. DOI: 10.1038/nrgastro.2015.35.
  13. Губич ОИ, Дашкова ЯЮ, Кривленя ИН. Сравнительная оценка гепатопротекторных свойств растительных адаптогенов на экспериментальной модели хронического алкогольного поражения печени in vivo. Журнал Белорусского государственного университета. Биология. 2019;1:54–62. DOI: 10.33581/2521-1722-2019-1-54-62.
  14. Лазебник ЛБ, Голованова ЕВ, Тарасова ЛВ, Кривошеев АБ, Сас ЕИ, Еремина ЕЮ и др. Алкогольная болезнь печени (АБП) у взрослых. Экспериментальная и клиническая гастроэнтерология. 2020;174(2):4–28. DOI: 10.31146/1682-8658-ecg-174-2-4-28.
  15. Терещенко ЮА, Терещенко СЮ. Бессимптомное повышение активности сывороточных аминотрансфераз: этапы диагностического поиска. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014;24(1):29–38. EDN: SENTMN.
  16. Звенигородская ЛА. Патогенетические и клинические особенности алкогольной и неалкогольной болезни печени. Медицинский совет. 2014;13:40–45. EDN: SWKXGP.
  17. Ливзан МА, Лялюкова ЕА, Лаптева ИВ. Алкогольная болезнь печени: современные аспекты диагностики и лечения. Медицинский совет. 2014;13:49–53. EDN: SWKXHJ.
  18. Маев ИВ, Андреев ДН, Дичева ДТ, Абдурахманов ДТ. Алкогольная болезнь печени: современное состояние проблемы. Терапевтический архив. 2014;86(4):108–116. EDN: SVPGYF.
  19. Соловьева НВ, Лейхтер СН, Соловьева ВА, Бичкаева ФА, Ишеков НС, Карякина ОЕ и др. Алкогольассоциированные нарушения липидного обмена. Клиническая лабораторная диагностика. 2022;67(12):705–709. DOI: 10.51620/0869-2084-2022-67-12-705-709.
  20. Jeon S, Carr R. Alcohol effects on hepatic lipid metabolism. Journal of Lipid Research. 2020;61(4):470–479. DOI: 10.1194/jlr.R119000547.
  21. Grases F, Melero G, Costa-Bauzá A, Prieto R, March JC. Urolithiasis and phytotherapy. International Urology and Nephrology. 1994;26(5):507–511. DOI: 10.1007/BF02767650.
  22. Han K-H, Hashimoto N, Fukushima M. Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes. World Journal of Gastroenterology. 2016;22(1):37–49. DOI: 10.3748/wjg.v22.i1.37.
  23. Michalak A, Lack T, Cichoż-Lach H. Oxidative stress – a key player in the course of alcohol-related liver disease. Journal of Clinical Medicine. 2021;10(14):3011. DOI: 10.3390/jcm10143011.
  24. Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World Journal of Gastroenterology. 2014;20(47):17756–17772. DOI: 10.3748/wjg.v20.i47.17756.
  25. Zhou R, Lin J, Wu D. Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis. Biochimica et Biophysica Acta (BBA) – General Subjects. 2014;1840(1):209–218. DOI: 10.1016/j.bbagen.2013.09.018.
  26. Tang Y, Li Y, Yu H, Gao C, Liu L, Xing M, et al. Quercetin attenuates chronic ethanol hepatotoxicity: implication of «free» iron uptake and release. Food and Chemical Toxicology. 2014;67:131–138. DOI: 10.1016/j.fct.2014.02.022.
  27. Tan HK, Yates E, Lilly K, Dhanda AD. Oxidative stress in alcohol-related liver disease. World Journal of Hepatology. 2020;12(7):332–349. DOI: 10.4254/wjh.v12.i7.332.
  28. Куркин ВА, Авдеева ЕВ, Правдивцева ОЕ, Куркина АВ, Рыжов ВМ, Росихин ДВ и др. Сравнительное исследование антиоксидантной активности некоторых флавоноидов и гепатопротекторных лекарственных препаратов на основе плодов расторопши пятнистой. Современные проблемы науки и образования [Интернет]. 2016 [процитировано 10 декабря 2024 г.];6:15–27. Доступно по: https://science-education.ru/ru/article/view?id=25833.

Downloads

Published

2025-04-04

Issue

No. 1 (2025): Experimental Biology and Biotechnology

Section

Biochemistry

License

The authors who are published in this journal agree to the following:

  1. The authors retain copyright on the work and provide the journal with the right of first publication of the work on condition of license Creative Commons Attribution-NonCommercial. 4.0 International (CC BY-NC 4.0).
  2. The authors retain the right to enter into certain contractual agreements relating to the non-exclusive distribution of the published version of the work (e.g. post it on the institutional repository, publication in the book), with the reference to its original publication in this journal.
  3. The authors have the right to post their work on the Internet (e.g. on the institutional store or personal website) prior to and during the review process, conducted by the journal, as this may lead to a productive discussion and a large number of references to this work. (See The Effect of Open Access.)

How to Cite

Hubich, A. I. ., & Shpak, A. P. . (2025). The investigation of hepatoprotective and antioxidant properties of Osmanthus fragrans on experimental model of chronic alcoholic liver damage in vivo. Experimental Biology and Biotechnology, 1, 4-11. https://journals.bsu.by/index.php/biology/article/view/6845